Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Commentary

  • 2,019 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 201
  • 202
  • Next →
Serotonin biosynthesis emerges as a metabolic driver in prostate cancer therapy resistance
Kevin Holm, Neil A. Bhowmick
Kevin Holm, Neil A. Bhowmick
View: Text | PDF

Serotonin biosynthesis emerges as a metabolic driver in prostate cancer therapy resistance

  • Text
  • PDF
Abstract

Advanced prostate cancer frequently escapes androgen receptor pathway inhibition through mechanisms including restored androgen signaling, lineage plasticity, and metabolic adaptation. Neuroendocrine prostate cancer (NEPC) can emerge as an androgen-insensitive lineage and has mostly been studied in the context of its transcriptional and epigenetic reprogramming. However, evidence increasingly supports the requirement for metabolic rewiring across a variety of pathways in the transition to NEPC. In this issue of the JCI, Wei et al. demonstrated that serotonin metabolism regulated by tryptophan hydroxylase 1 (TPH1) stabilizes the plastic state of NEPC by supporting serotonin-based posttranslational modification (serotonylation) of mTOR and FOXM1/E2F1 activation. These findings position TPH1 as both a neuroendocrine marker and a functional mediator of hormone therapy resistance. Because metabolic escape can involve many pathways, biomarker-guided patient selection will be required for translating these findings to an intervention. Accordingly, targeting TPH1 may delay or reverse therapy-induced NEPC in selected patients.

Authors

Kevin Holm, Neil A. Bhowmick

×

Neutrophils close the loop: self-sustaining splenic myelopoiesis in cancer
Hongpeng Jia
Hongpeng Jia
View: Text | PDF

Neutrophils close the loop: self-sustaining splenic myelopoiesis in cancer

  • Text
  • PDF
Abstract

Cancer-associated extramedullary hematopoiesis is increasingly recognized as a systemic mechanism of immune evasion. Although the spleen is an important site of tumor-induced myelopoiesis, how this process is locally maintained remains incompletely understood. In this issue of the JCI, Zhu and colleagues identify a self-reinforcing circuit between tumor-associated neutrophils and splenic hematopoietic stem and progenitor cells (HSPCs). They show that neutrophil-derived, NOX2-dependent ROS activated forkhead box O1 (FOXO1) in neighboring HSPCs, inducing dynamin-related protein 1 dependent (DRP1-dependent) mitochondrial fission and a myeloid-biased, granulocyte-macrophage CSF–producing (GM-CSF–producing) progenitor state. The resulting neutrophil progeny further reinforced oxidative stress, thereby sustaining immunosuppressive myelopoiesis in the spleen. Disruption of this circuit through genetic, pharmacologic, or spleen-directed interventions reduced suppressive myeloid cell production, enhanced cytotoxic T cell activity, and restrained tumor growth. These findings establish mature neutrophils as active regulators of pathological splenic hematopoiesis and identify the neutrophil/ROS/FOXO1/DRP1 axis as a potential therapeutic target in cancer.

Authors

Hongpeng Jia

×

Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity
Xianglin Huang, Bryan L. Roth
Xianglin Huang, Bryan L. Roth
View: Text | PDF

Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity

  • Text
  • PDF
Abstract

Pancreatic islet macrophages are important immunometabolic regulators of β cell function, particularly in obesity-associated type 2 diabetes. Previous studies have established that pancreatic islet macrophages communicate with β cells through either the release of cytokines and growth factors, or direct cell–cell contact. In this issue of the JCI, Singh et al. used chemogenetics to identify a Gq/AMPK pathway that remodels sphingolipid metabolism. This pathway links macrophages to β cells through a CD36-dependent mechanism that reduces insulin secretion. Surprisingly, the orphan GPCR GPR18 was identified as the receptor that engages this pathway. These findings expand our understanding in macrophage–β cell communication and identify GPR18 as a potential therapeutic target for type 2 diabetes.

Authors

Xianglin Huang, Bryan L. Roth

×

Cell state programs offer a potential axis for classifying neuroendocrine tumors
Parambir S. Dulai
Parambir S. Dulai
View: Text | PDF

Cell state programs offer a potential axis for classifying neuroendocrine tumors

  • Text
  • PDF
Abstract

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) arise from hormone-producing cells in the gut and pancreas. Despite increasing incidence of these tumors, therapeutic options remain limited. Well-differentiated GEP-NETs are classified by anatomic site, morphology, and proliferation indices, but this approach offers limited prognostic resolution among phenotypically similar tumors and constrains personalization of treatment decisions. In this issue of the JCI, Karam, Hoffman, and colleagues profiled 38 pancreatic and small-intestinal NETs using joint single-nucleus RNA and ATAC sequencing and projected the resulting malignant cell–associated programs onto matched spatial transcriptomes. Two conserved malignant states emerged: neuronal-like and secretory neuroendocrine. These states span a continuum in both organ sites, are enriched for largely different transcription factor motifs, and occupy distinct microenvironmental niches. Secretory program scores trended higher in metastatic disease and may carry prognostic value. Taken together, these data describe NET heterogeneity as a cell state axis linked to tissue architecture.

Authors

Parambir S. Dulai

×

Beyond motor rescue: defining adequate SMN restoration in spinal muscular atrophy
Crystal Jing Jing Yeo
Crystal Jing Jing Yeo
View: Text | PDF

Beyond motor rescue: defining adequate SMN restoration in spinal muscular atrophy

  • Text
  • PDF
Abstract

Spinal muscular atrophy (SMA) is characterized by motor neuron degeneration due to deficiency in the survival of motor neuron (SMN) protein. Disease-modifying therapies have transformed outcomes in SMA, while also revealing an increasingly complex spectrum of residual disease biology. In this issue of the JCI, Tapken, Rahmel-Stein, and colleagues demonstrated cell-specific SMN expression and persistent alterations in peripheral immune cell populations in nusinersen- or risdiplam-treated adults with SMA. Their findings extend the question of selective vulnerability beyond motor neurons and raise an increasingly important therapeutic question: What constitutes adequate SMN restoration? This Commentary considers how cell type, developmental timing, SMN requirement, and downstream response may shape treatment-modified SMA, with implications for systemic and CNS-directed therapies.

Authors

Crystal Jing Jing Yeo

×

Pulmonary arterial hypertension–associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases
Michael W. Schwartz, Karin E. Bornfeldt
Michael W. Schwartz, Karin E. Bornfeldt
View: Text | PDF

Pulmonary arterial hypertension–associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases

  • Text
  • PDF
Abstract

Growing evidence shows that the risk of cognitive impairment is increased across a range of metabolic and cardiovascular diseases, but underlying mechanisms remain poorly understood. One possibility involves activation of microglia, a glial cell type of the central nervous system with morphological and transcriptional features comparable to resident macrophages in other tissues that plays specialized roles in supporting neuronal and brain function. Combining clinical investigation in pulmonary arterial hypertension (PAH) cohorts with mouse model and microglial cell culture studies, a study by Okawa, Shi, and colleagues in this issue of the JCI adds compelling, albeit indirect, evidence linking impaired lysosomal lipid handling in both endothelial cells and microglia to a specific neurological disorder associated with PAH. The findings open opportunities for understanding how cardiopulmonary disease predisposes to neurodegeneration.

Authors

Michael W. Schwartz, Karin E. Bornfeldt

×

B cells and the therapeutic index of checkpoint blockade
Chuan-Yuan Li
Chuan-Yuan Li
View: Text | PDF

B cells and the therapeutic index of checkpoint blockade

  • Text
  • PDF
Abstract

Combined CTLA-4 and PD-1 blockade is effective in treating melanoma and additional cancers but frequently causes immune-related adverse events (irAEs). irAEs cause treatment disruption and discontinuation and remain difficult to manage clinically. In this issue, Dhodapkar and colleagues assessed data from a small randomized clinical trial testing rituximab-mediated B cell depletion in combined CTLA-4/PD-1 blockade–treated patients with advanced melanoma. Despite premature discontinuation of the trial due to a high rate of rituximab hypersensitivity, they report that preemptive B cell depletion was associated with fewer severe toxicities without evident loss of antitumor activity. These findings raise broader questions about the organization of checkpoint-induced autoimmunity, the emerging concept of immune reset, and the compartment-specific roles of B cells in antitumor immunity.

Authors

Chuan-Yuan Li

×

Insulin sensitivity and mitochondrial homeostasis connect lactation to maternal metabolic health
Laura L. Hernandez
Laura L. Hernandez
View: Text | PDF

Insulin sensitivity and mitochondrial homeostasis connect lactation to maternal metabolic health

  • Text
  • PDF
Abstract

Lactation insufficiency in postpartum women has been associated with obesity and insulin resistance, among other risk factors. Challenges related to translating findings from animal models of lactation and the limited ability to study pregnant and lactating women in clinical trials have impeded more detailed mechanistic understanding of this relationship. In this issue of the JCI, Meng et al. combined studies in human milk samples and in vitro mammary epithelial cell models from humans and rodents to provide compelling evidence that mitochondrial dysfunction mediates the link between insulin resistance and lactation insufficiency. Notably, they observed that chronic exposure to high levels of insulin led to mitochondrial fragmentation and loss of volume in mouse mammary epithelial cells. This framework linking mitochondria, insulin signaling, and lactation should be extended to in vivo models and primary human tissues to better define the mechanisms supporting successful lactation.

Authors

Laura L. Hernandez

×

Cells heal themselves: gene-edited hematopoietic stem cells restore frataxin deficiency in multiple organs
Lucy R. Osborne
Lucy R. Osborne
View: Text | PDF

Cells heal themselves: gene-edited hematopoietic stem cells restore frataxin deficiency in multiple organs

  • Text
  • PDF
Abstract

Friedreich’s ataxia (FRDA) is a triplet repeat expansion disorder with multisystem, progressive symptoms caused by reduced frataxin protein levels and compromised mitochondrial function. Restoration of frataxin protein is a focus of clinical trials involving adeno-associated viral vectors, but substantial barriers exist because of the immune response they elicit. In this issue of the JCI, Sivakumar et al. harnessed CRISPR/Cas9 editing of endogenous hematopoietic stem and progenitor cells (HSPCs) to excise the frataxin gene (FXN) repeat expansion ex vivo, followed by autologous transplantation. A single, systemic infusion of corrected HSPCs resulted in long-term engraftment and sustained multiorgan benefit in a humanized mouse model of FRDA. This improvement in brain, cardiac, and pancreatic symptoms, mediated by myeloid progeny of the engrafted stem cells, provides strong support for the potential effectiveness of this approach in humans and bypasses the need to correct the FXN deficiency in the affected tissue and cells directly.

Authors

Lucy R. Osborne

×

Good vibes keep worries at bay: a prefrontal-hypothalamic pathway engages positive affect to mitigate fear
Quan-Son Eric Le, Luis E. Rosas-Vidal
Quan-Son Eric Le, Luis E. Rosas-Vidal
View: Text | PDF

Good vibes keep worries at bay: a prefrontal-hypothalamic pathway engages positive affect to mitigate fear

  • Text
  • PDF
Abstract

Trauma-related neuropsychiatric disorders are commonly treated with exposure-based therapy, an approach based on fear extinction, in which fear memory and expression are suppressed by repeated exposure to the inciting fear stimulus. Fear extinction–focused research often investigates mechanisms of fear inhibition, but positive affect may also contribute to facilitating extinction. In this issue of the JCI, Lin et al. used activity-dependent neuronal labeling in a model of fear extinction to tag extinction-activated medial prefrontal cortex (mPFC) ensembles, identifying functionally distinct projections to the zona incerta (ZI) and supramamillary nucleus (SuM). While mPFC-ZI projections governed extinction retrieval, mPFC-SuM projections encoded positive affect and reinforced fear extinction persistence. Additionally, Lin et al. discovered that SIRT1-expressing mPFC-SuM extinction-recruited projections control extinction relapse vulnerability, showing that SIRT1 overexpression can be leveraged to reduce fear relapse. Overall, this study shows that key cortico-hypothalamic projections manage extinction retrieval and positive affect to promote fear extinction.

Authors

Quan-Son Eric Le, Luis E. Rosas-Vidal

×
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 201
  • 202
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts